Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Lamotrigine Adjunctive Therapy to Lithium and Divalproex in Depressed Patients with Rapid Cycling Bipolar Disorder and a Recent Substance Use Disorder: A 12-week, Double-Blind, Placebo-Controlled Pilot Study
1
x
$
30.00
P. Murali Doraiswamy, MD: Donepezil for Cognitive Decline Following Coronary Artery Bypass Surgery: A Pilot Randomized Controlled Trial
1
x
$
30.00
Teaching Monograph Grand Round Series: Quality-of-Life and Pharmacoeconomic Considerations of Obsessive-Compulsive Disorder
1
x
$
10.00
Publisher’s Statement: Raising Cain
1
x
$
0.00
The Hamilton Rating Scale for Depression
1
x
$
0.00
Johannes Hamann, MD: How Long do Psychiatrists Wait for Response Before They Switch to Another Antipsychotic?
1
x
$
30.00
Alzheimer’s and Dementia Guidelines and Tables
1
x
$
30.00
Assessing the Older Cancer Patient
1
x
$
0.00
M. Ojinga Harrison, MD: Antipsychotic Medications and Sudden Cardiac Death
1
x
$
30.00
Colorectal Cancer Screening: How Are We Doing and How Can We Improve?
1
x
$
0.00
Gregory M. Asnis, MD: IFN-Induced Depression: A Role for NSAIDs
1
x
$
30.00
Can a ‘Shot’ Help Prevent Youth Re-Incarceration? Case Report on Use of a Long-Acting Injectable Antipsychotic in Incarcerated Youth (OPEN ACCESS)
1
x
$
0.00
Igor Elman, MD: Acute Cortisol Administration Triggers Craving in Individuals with Cocaine Dependence
1
x
$
30.00
Guest Editor: Research Needs in Myeloma
1
x
$
0.00
R. Bart Sangal, MD: What Is a Significant Response in Drug Studies of Attention- Deficit/Hyperactivity Disorder: Statistical Significance Is Necessary, But Is It Sufficient?
1
x
$
30.00
View Cart
Checkout
Home
Store
“R. Bart Sangal, MD: What Is a Significant Response in Drug Studies of Attention- Deficit/Hyperactivity Disorder: Statistical Significance Is Necessary, But Is It Sufficient?” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study
$
30.00
Add to cart
Details
MDMA to Treat PTSD in Adults
$
30.00
Add to cart
Details
Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a Primer
$
30.00
Add to cart
Details
Consistently Modest Antidepressant Effects in Clinical Trials: the Role of Regulatory Requirements (OPEN ACCESS)
$
0.00
Add to cart
Details
Struggling to find Effective Pharmacologic Options for Akathisia? B-CALM!
$
30.00
Add to cart
Details
Lithium-Induced Hyperparathyroidism: An Ill-defined Territory (OPEN ACCESS)
$
0.00
Add to cart
Details
Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression
$
30.00
Add to cart
Details
The Role of Religiosity and Guilt in Symptomatology and Outcome of Obsessive Compulsive Disorder
$
30.00
Add to cart
Details
Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder
$
30.00
Add to cart
Details
ADHD and Drug Holidays: Effects on Anthropometric Changes during Methylpenidate Treatment
$
30.00
Add to cart
Details
Can a ‘Shot’ Help Prevent Youth Re-Incarceration? Case Report on Use of a Long-Acting Injectable Antipsychotic in Incarcerated Youth (OPEN ACCESS)
$
0.00
Add to cart
Details
Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder
$
30.00
Add to cart
Details
Clozapine Prolongs Cortical Silent Period in Patients with Treatment- Resistant Schizophrenia
$
30.00
Add to cart
Details
Impact of the Omics-Based Biomarkers on the Mirtazapine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder
$
30.00
Add to cart
Details
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended- Release) in Adolescents with ADHD (OPEN ACCESS)
$
0.00
Add to cart
Details
Obsessive-Compulsive Disorder Driven by Aspects of Ritual Addiction: A Case Report and Review of Literature
$
30.00
Add to cart
Details
Brexpiprazole for the Treatment of Schizophrenia and Major Depressive Disorder: A Comprehensive Review of Pharmacological Considerations in Clinical Practice
$
30.00
Add to cart
Details
Lamotrigine and Stevens-Johnson Syndrome Prevention
$
30.00
Add to cart
Details
Brexanolone to Treat Postpartum Depression in Adult Women
$
30.00
Add to cart
Details
Hyperprolactinemia, Clinical Considerations, and Infertility in Women on Antipsychotic Medications
$
30.00
Add to cart
Details
Previous
1
…
6
7
8
…
44
Next
Page load link
Go to Top
